FDA Inspection
Diabetes Corporation of AmericaDiabetes Corporation of America – FDA Inspection, Jun 15, 2017
Record Details
This FDA Inspection record concerns Diabetes Corporation of America, with an inspection on June 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ff6a5957-8e28-4173-a940-c6ce71583e88
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017372
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- State Referral Letter
Other FDA inspections of Diabetes Corporation of America
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 20, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Diabetes Corporation of America
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.